Crestwood Advisors Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Buy
2,297
+144
+7% +$30.9K 0.01% 502
2026
Q1
$476K Sell
2,153
-1,745
-45% -$427K 0.01% 436
2025
Q4
$988K Sell
3,898
-1,865
-32% -$468K 0.02% 284
2025
Q3
$1.43M Sell
5,763
-415
-7% -$99.3K 0.02% 248
2025
Q2
$1.48M Sell
6,178
-11
-0.2% -$2.56K 0.03% 238
2025
Q1
$1.4M Buy
+6,189
New +$1.36M 0.03% 238

Other funds holding STE

Crestwood Advisors Group's STE Position: Q2 2026 in Review

Crestwood Advisors Group increased its Steris (STE) stake by 6.7% in Q2 2026, buying an estimated $30.9K and bringing the position to 2,297 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #502.

Crestwood Advisors Group first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.48M in Q2 2025. 831 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Crestwood Advisors Group held 2,297 shares of Steris worth $484K as of Q2 2026.
  • Crestwood Advisors Group bought 144 Steris shares in Q2 2026, an estimated $30.9K.
  • Steris made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #502 holding.
  • Crestwood Advisors Group first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • Crestwood Advisors Group's Steris position peaked at $1.48M in Q2 2025.
  • 831 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.